JAZZ Jazz Pharmaceuticals
- 109.380
- +0.820+0.76%
- 109.380
- 0.0000.00%
Jazz Pharmaceuticals News
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Mary Elizabeth
Jazz Pharmaceuticals | 8-K: Current report
Jazz Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Jazz Pharmaceuticals | 8-K: Current report
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ENRIGHT PATRICK G
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Winningham Rick E
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Smith Mark Douglas
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RIEDEL NORBERT G
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ORiordan Anne
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director O'Keefe Kenneth W
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director McSharry Heather Ann
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Cook Jennifer E.
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Pearce Samantha
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kennedy Patrick
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Mulligan Seamus
Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hamill Laura
Jazz Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Jazz Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Jazz Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Jazz Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
No Data